H. Mameghan et al., ANALYSIS OF FAILURE FOLLOWING DEFINITIVE RADIOTHERAPY FOR INVASIVE TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, International journal of radiation oncology, biology, physics, 31(2), 1995, pp. 247-254
Citations number
26
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To assess prognostic factors for bladder relapse and distant
failure following definitive radiotherapy for invasive transitional ce
ll carcinoma (TCC) of the bladder. Methods and Materials: Retrospectiv
e review of patients treated in the period 1977 to 1990 by definitive
radiotherapy. The factors studied included age, sex, T stage, histolog
ical grade, tumor multiplicity, ureteric obstruction, total radiation
dose, and use of neoadjuvant chemotherapy, The endpoints studied were
bladder relapse and distant failure. Results: There were 342 patients
with a mean follow-up time of 7.9 years. Bladder relapse was observed
in 159 patients, The overall actuarial bladder relapse rate at 5 years
was 55% (SE = 3%). Prognostic factors for a higher bladder relapse ra
te were: tumor multiplicity (p < 0.001), presence of ureteric obstruct
ion (p = 0.001), and higher T stage (p = 0.044), Distant failure occur
red in 39 patients, The overall actuarial distant failure rate at 5 ye
ars was 28% (SE = 3%). Prognostic factors for a higher distant failure
rate were: ureteric obstruction (p = 0.003) and higher T stage (p = 0
.030). Conclusion: In our study, patients with invasive bladder TCC fe
ll into distinct prognostic groups determined by the three independent
factors, ureteric obstruction, tumor multiplicity, and T stage. These
factors provided estimated risks of bladder relapse by 5 years which
ranged from 34% to 91%. Knowledge of these prognostic factors can help
in the selection of patients more suited for bladder preservation by
definitive radiotherapy.